MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Clinical trial NCT00602329 · TERMINATED
Trial details
- NCT number
- NCT00602329
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.